Sort
23,748 grants matching “melanoma”
Nucleoporin NUP205-driven Novel Pathway in Melanoma Tumor Growth and Metastasis
$383,156Narendra Wajapeyee · Yale University · R01 · FY2017 · CA
Regulators of Translation Elongation Factor eEF1A
$383,101Terri Goss Kinzy · Rbhs-Robert Wood Johnson Medical School · R01 · FY2016 · GM
Regulators of Translation Elongation Factor eEF1A
$383,101Terri Goss Kinzy · Rbhs-Robert Wood Johnson Medical School · R01 · FY2014 · GM
Regulators of Translation Elongation Factor eEF1A
$383,101Terri Goss Kinzy · Rbhs-Robert Wood Johnson Medical School · R01 · FY2015 · GM
Focused kV X-ray Modulated Conformal Radiotherapy for Small Targets
$382,974Wu Liu · Stanford University · R01 · FY2021 · EB
Nucleoporin NUP205-driven Novel Pathway in Melanoma Tumor Growth and Metastasis
$382,966Narendra Wajapeyee · Yale University · R01 · FY2016 · CA
Southwest Oncology Group
$382,959Patrick J Stiff · Loyola University Chicago · U10 · FY2008 · CA
Gene regulatory network controlling neural crest derived formation of facial cartilage
$382,950Marianne Bronner-Fraser · California Institute Of Technology · R01 · FY2025 · DE
Gene regulatory network controlling neural crest derived formation of facial cartilage
$382,950Marianne Bronner-Fraser · California Institute Of Technology · R01 · FY2021 · DE
Gene regulatory network controlling neural crest derived formation of facial cartilage
$382,950Marianne Bronner-Fraser · California Institute Of Technology · R01 · FY2023 · DE
Novel Receptor-Targeting Peptides for Melanoma Therapy
$382,939Yubin Miao · University Of Colorado Denver · R01 · FY2022 · CA
Cytotoxic lymphocyte function PET imaging to predict cancer immunotherapy response
$382,836Umar Mahmood · Massachusetts General Hospital · R01 · FY2018 · CA
Cytotoxic lymphocyte function PET imaging to predict cancer immunotherapy response
$382,836Umar Mahmood · Massachusetts General Hospital · R01 · FY2020 · CA
Cytotoxic lymphocyte function PET imaging to predict cancer immunotherapy response
$382,836Umar Mahmood · Massachusetts General Hospital · R01 · FY2021 · CA
Cytotoxic lymphocyte function PET imaging to predict cancer immunotherapy response
$382,836Umar Mahmood · Massachusetts General Hospital · R01 · FY2017 · CA
Enhancing TIL populations and immunotherapy efficacy in melanoma by modulating fucosylation
$382,794Eric Kirk Lau · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2019 · CA
Novel methods for identifying genetic interactions in cancer prognosis
$382,775Shuangge Ma · Yale University · R01 · FY2016 · CA
Core 1: Biospecimen and Data Management Core
$382,650John B Sunwoo · Stanford University · U54 · FY2018 · CA
OCULAR MELANOMA
$382,644University Of Pennsylvania · U10 · FY2002 · EY
Targeted Chemoprevention for Melanoma
$382,639Gavin P. Robertson · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2013 · CA
Lassa-VSV targets and kills glioma, and is not neurotoxic
$382,622Anthony N Van Den Pol · Yale University · R01 · FY2016 · CA
Lassa-VSV targets and kills glioma, and is not neurotoxic
$382,622Anthony N Van Den Pol · Yale University · R01 · FY2017 · CA
Targeting Lag-3 and PD -1 in Myeloid Cells of GBM
$382,582Michael Lim · Stanford University · R01 · FY2024 · NS
EASTERN COOPERATIVE ONCOLOGY GROUP
$382,540Tufts Medical Center · U10 · FY2003 · CA
TRITIUM NMR ANALYSIS OF ART817: METASTIC MELANOMA &PROTEIN KINASE C
$382,503University Of Calif-Lawrenc Berkeley Lab · P41 · FY2001 · RR